LivaNova (LIVN) Gross Margin Growth (1y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -67.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -54.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -265.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 62.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -65.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 9.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 610.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -359.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 58.00 |
| 10 | LivaNova | 4.03 Bn | 3.45 Bn | 243.75 Mn | -96.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -96.00 |
| Dec 31, 2025 | -18.00 |
| Sep 30, 2025 | -104.00 |
| Jun 30, 2025 | 34.00 |
| Mar 31, 2025 | -65.00 |
| Dec 31, 2024 | 1,027.00 |
| Sep 30, 2024 | -105.00 |
| Jun 30, 2024 | -237.00 |
| Mar 31, 2024 | 282.00 |
| Dec 31, 2023 | -1,042.00 |
| Sep 30, 2023 | 287.00 |
| Jun 30, 2023 | -271.00 |
| Mar 31, 2023 | -405.00 |
| Dec 31, 2022 | -790.00 |
| Sep 30, 2022 | 105.00 |
| Jun 30, 2022 | 740.00 |
| Mar 31, 2022 | 414.00 |
| Dec 31, 2021 | 1,275.00 |
| Sep 30, 2021 | 513.00 |
| Jun 30, 2021 | 204.00 |
| Mar 31, 2021 | -220.00 |
| Dec 31, 2020 | 192.00 |
| Sep 30, 2020 | -646.00 |
| Jun 30, 2020 | -986.00 |
| Mar 31, 2020 | 179.00 |
| Dec 31, 2019 | -955.00 |
| Sep 30, 2019 | 386.00 |
| Jun 30, 2019 | 550.00 |
| Mar 31, 2019 | 168.00 |
| Dec 31, 2018 | 773.00 |
| Sep 30, 2018 | -34.00 |
| Jun 30, 2018 | 98.00 |
| Mar 31, 2018 | -36.00 |
| Dec 31, 2017 | 1,157.00 |
| Sep 30, 2017 | -11.00 |
| Jun 30, 2017 | 746.00 |
| Mar 31, 2017 | 661.00 |
| Oct 18, 2015 | -491.00 |